We just received data on a new analyst forecast for $BIOX. Austin Moeller from Canaccord Genuity set a price target of 2.5 for BIOX.
To track analyst ratings and price targets for $BIOX, check out Quiver Quantitative's $BIOX forecast page.
$BIOX Price Targets
Multiple analysts have issued price targets for $BIOX recently. We have seen 2 analysts offer price targets for $BIOX in the last 6 months, with a median target of $4.25.
Here are some recent targets:
- Austin Moeller from Canaccord Genuity set a target price of $2.5 on 09/10/2025
- Kristen Owen from Oppenheimer set a target price of $6.0 on 07/15/2025
$BIOX Hedge Fund Activity
We have seen 12 institutional investors add shares of $BIOX stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAVEN SECURITIES LTD removed 85,673 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $382,958
- CITADEL ADVISORS LLC added 59,233 shares (+106.4%) to their portfolio in Q2 2025, for an estimated $264,771
- JANE STREET GROUP, LLC added 45,193 shares (+inf%) to their portfolio in Q2 2025, for an estimated $202,012
- ARDSLEY ADVISORY PARTNERS LP added 45,000 shares (+4.7%) to their portfolio in Q2 2025, for an estimated $201,150
- UBS GROUP AG removed 43,628 shares (-47.3%) from their portfolio in Q2 2025, for an estimated $195,017
- LAZARD ASSET MANAGEMENT LLC removed 35,919 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $160,557
- SUMITOMO MITSUI TRUST GROUP, INC. removed 35,919 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $160,557
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
